Transamerica Small Cap Growth R4 holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Transamerica Small Cap Growth R4 TSPFX
- NAV / 1-Day Return 5.32 / +0.76 %
- Total Assets 81.6M
-
Adj. Expense Ratio
1.150%
- Expense Ratio 1.150%
- Distribution Fee Level Low
- Share Class Type Retirement, Medium
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 5,000
- Status Open
- TTM Yield 0.00
- Turnover 47%
USD | NAV as of Oct 06, 2026 | 1-Day Return as of Oct 06, 2026, 12:08 AM GMT+0
Morningstar’s Analysis TSPFX
Will TSPFX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Ligand Pharmaceuticals Inc | 4.42 | 4M | Healthcare |
Oceaneering International Inc | 3.30 | 3M | Energy |
Chime Financial Inc Ordinary Shares - Class A | 3.01 | 3M | Technology |
Excelerate Energy Inc Class A | 2.88 | 2M | Energy |
HealthEquity Inc | 2.64 | 2M | Healthcare |
PDF Solutions Inc | 2.56 | 2M | Technology |
Willdan Group Inc | 2.56 | 2M | Industrials |
Casella Waste Systems Inc Class A | 2.52 | 2M | Industrials |
Stevanato Group SpA | 2.51 | 2M | Healthcare |
UL Solutions Inc Class A common stock | 2.46 | 2M | Industrials |